共 277 条
[1]
Attal M(1996)A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe francais du myelome N Engl J Med 335 91-97
[2]
Harousseau JL(2008)Improved survival in multiple myeloma and the impact of novel therapies Blood 111 2516-2520
[3]
Stoppa AM(2003)A phase 2 study of bortezomib in relapsed, refractory myeloma N Engl J Med 348 2609-2617
[4]
Sotto JJ(2002)Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma Blood 100 3063-3067
[5]
Fuzibet JG(1999)Antitumor activity of thalidomide in refractory multiple myeloma N Engl J Med 341 1565-1571
[6]
Rossi JF(1999)Total therapy with tandem transplants for newly diagnosed multiple myeloma Blood 93 55-65
[7]
Casassus P(2003)Single versus double autologous stem-cell transplantation for multiple myeloma N Engl J Med 349 2495-2502
[8]
Maisonneuve H(2009)Tandem versus single autologous hematopoietic cell transplantation for the treatment of multiple myeloma: a systematic review and meta-analysis J Natl Cancer Inst 101 100-106
[9]
Facon T(2002)Improved outcome of allogeneic transplantation in high-risk multiple myeloma patients after nonmyeloablative conditioning J Clin Oncol 20 1295-1303
[10]
Ifrah N(2001)Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983–93 and 1994–8 at European group for blood and marrow transplantation centres Br J Haematol 113 209-216